It is important to note that: Most clinical trials have follow-up periods of 25 years, which may not capture very long-term cancer development Patients with type 2 diabetes and obesity have baseline elevated cancer risks due to metabolic factors Post-marketing surveillance continues to monitor for rare or delayed adverse events The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) continue to review safety data as part of ongoing pharmacovigilance activities, and no major cancer-related safety signals have emerged that would warrant withdrawal or significant restriction of these medicines
My all-time go-to antioxidant power house, the mother of all antioxidants, the maestro of cell protection, is glutathione
Figure 8 Headache According to the study, headaches were more common in the ROSE-010 treatment group (100 g) than in the placebo group
LegitScript certified
Includes: retatrutide 10mg (lyophilized, ≥98% purity per supplier batch spec), bacteriostatic water 5ml, 2 ×
The Short Answer Tirzepatide produces more weight loss on average